Clinical Trials Directory

Trials / Unknown

UnknownNCT01123044

Transplantation of Cultivated Corneal Epithelial Sheet in Patients With Ocular Surface Disease

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
42 (estimated)
Sponsor
Ministry of Health, Malaysia · Other Government
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to assess if transplantation of cultivated corneal epithelial stem cells could restore vision in patients with severe ocular surface disorder with a favourable safety profile that warrants further comparative study.

Detailed description

Objectives: Efficacy: To determine the efficacy of cultivated corneal epithelial stem cells as a treatment for patients with severe ocular surface disorder. The corneal limbal epithelial stem cell transplant (CLET) successful outcome will be measured by improvement of vision, maintenance of corneal re-epithelisation with absence of recurrence of surface disease and subjective improvement of symptoms.

Conditions

Interventions

TypeNameDescription
BIOLOGICALconservativeUndergo autologous transplantation of limbal epithelial cells cultured on amniotic membrane
PROCEDUREMedical TherapyUnder usual care treatment

Timeline

Start date
2011-08-01
Primary completion
2012-06-01
Completion
2012-09-01
First posted
2010-05-14
Last updated
2011-07-08

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT01123044. Inclusion in this directory is not an endorsement.

Transplantation of Cultivated Corneal Epithelial Sheet in Patients With Ocular Surface Disease (NCT01123044) · Clinical Trials Directory